Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
24.30
-0.46 (-1.88%)
Mar 3, 2026, 2:27 PM EST - Market open
Arcutis Biotherapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$31.86
Upside
+31.14%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $37 → $35 | Buy | Maintains | $37 → $35 | +44.06% | Mar 2, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $34 → $35 | Strong Buy | Maintains | $34 → $35 | +44.06% | Feb 27, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $30 → $35 | Strong Buy | Maintains | $30 → $35 | +44.06% | Feb 26, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $34 | Strong Buy | Maintains | $30 → $34 | +39.95% | Feb 26, 2026 |
| Needham | Needham | Strong Buy Maintains $31 → $36 | Strong Buy | Maintains | $31 → $36 | +48.18% | Feb 26, 2026 |
| Needham | Needham | Strong Buy Maintains $30 → $31 | Strong Buy | Maintains | $30 → $31 | +27.60% | Jan 26, 2026 |
| Mizuho | Mizuho | Buy Maintains $32 → $37 | Buy | Maintains | $32 → $37 | +52.29% | Nov 28, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $19 → $29 | Hold | Maintains | $19 → $29 | +19.37% | Oct 30, 2025 |
| Needham | Needham | Strong Buy Maintains $22 → $30 | Strong Buy | Maintains | $22 → $30 | +23.48% | Oct 28, 2025 |
| Needham | Needham | Strong Buy Maintains $20 → $22 | Strong Buy | Maintains | $20 → $22 | -9.45% | Aug 7, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $18 | Hold | Initiates | $18 | -25.91% | Jul 25, 2025 |
| Needham | Needham | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | -17.68% | May 23, 2025 |
| Needham | Needham | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | -17.68% | Apr 9, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Apr 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | -21.79% | Apr 3, 2025 |
| Needham | Needham | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | -17.68% | Apr 3, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.